-
Nov 10 |
Diagnostics World | Many in vitro diagnostic (IVD) and over-the-counter test makers became interested in wellness claims after the FDA’s dispute with Whoop. They hoped to avoid standard medical device requirements. According to Dan Simpson, director of regulatory affairs at DCN Dx, that path is narrower than many assume.
More
-
Nov 05 |
Diagnostics World News | Development of next-generation drugs for treating systemic inflammation and cognitive impairment is ready to begin, backed by a study linking abnormalities in the cerebellum and frontal lobe regions of the brain in pulmonary hypertension patients to the same processes driving the disease in their lungs and heart.
More
-
Nov 03 |
Diagnostics World News | An analysis of more than 900,000 genomes sets a baseline for what a typical human genome contains, with implications for screening, VUS reporting, and polygenic scores.
More
-
Oct 28 |
Diagnostics World | Zenflow closes $52M Series D to launch its BPH implant; Arboretum launches with $30M for clinical genetic testing in common diseases; and more.
More
-
Oct 27 |
Diagnostics World News | Mursla Bio publishes peer-reviewed validation of its liver-focused extracellular vesicle liquid biopsy platform; new products from GE HealthCare and Geneoscopy; and more.
More
-
Oct 20 |
Diagnostics World | New blood tests have the potential to transform how Alzheimer's disease is diagnosed. Yet, despite being approved in the US and more than 30 countries across Europe and Asia-Pacific, uptake in community practice remains limited. Bridging this gap requires robust clinical evidence demonstrating that these blood tests can be deployed safely and effectively in community care.
More
-
Oct 19 |
Diagnostics World News | Melanin absorption has been a recognized if widely overlooked factor in pulse oximetry for decades, which can result in a measurement bias that overestimates oxygen levels in people with darker skin tones. A device under development in the Advanced Integrated Circuits and Systems Lab at Tufts University seeks to force attention to the issue while also adding a blood pressure monitoring feature.
More
-
Oct 08 |
Diagnostics World | A study published July in Allergy is one of the largest and most thorough longitudinal studies to date assessing how the infant skin microbiome changes in conjunction with atopic dermatitis (more commonly referred to as eczema), food sensitization, and food allergy.
More
-
Oct 06 |
Bio-IT World | Diagnostic labs have an underappreciated opportunity to team up with health plans on pilot programs focused on improving access to testing and reducing health disparities. The laboratory community should be thinking beyond medical policy coverage to design for completion, measure and address the gaps, and share accountability for action, advises Mark Hiatt, M.D., chief medical officer for the accreditation organization RadSite.
More
-
Oct 01 |
Diagnostics World | Funding news from around the biotech space including investments in human tissue testing, oncology trial control data, AI protein design, more.
More
-
Nov 12 |
Share of Answer Connects AI visibility audits with prioritized actions to help biopharma teams improve how brands and disease education content are represented in AI-generated answers
More
-
Nov 12 |
One year after launching its ultrafast RNA-Seq service, Plasmidsaurus has reached more than 9,000 researchers across 1,000+ institutions, processing hundreds of thousands of samples to date.
More
-
Nov 12 |
• Assay enables comprehensive pharmacogenetic testing to support safer, personalised chemotherapy treatment for cancer patients
• Southern Cross Diagnostics to supply IVD assay to clinical diagnostics laboratories in Australia
More
-
Nov 12 |
The new START site at the IRCCS Istituto Nazionale Tumori Regina Elena will expand access to cancer clinical trials for patients in a major European oncology market.
More
-
Nov 12 |
Biognosys Group, a fully owned affiliate of Bruker Corporation, today announced the launch of Industrialized Discovery.
More
-
Nov 12 |
Lilly and Hims & Hers have partnered to expand access to FDA-approved Zepbound and Foundayo through telehealth. Monthly self-pay prices start at $299 for Zepbound and $149 for Foundayo.
More
-
Oct 30 |
CluePoints, a leading provider of Risk-Based Quality Management (RBQM) and clinical data quality oversight software, has been named a finalist in the Data Analytics/Business Intelligence category at the 2026 Fierce Life Sciences Innovation Awards.
More
-
Oct 30 |
Takara Bio Europe announces the introduction of a GMP-grade version of Cellartis® MSC EV Wonder™ for the efficient and scalable production of extracellular vesicles from human mesenchymal stem cells.
More
-
Oct 30 |
DCN Dx has acquired BioSouthTech, expanding access to diverse patient populations and biospecimens across Latin America. The acquisition strengthens support for diagnostic and drug development in oncology, neurology, autoimmune disease, and infectious disease. Learn more: dcndx.com/services/biospecimen
More
-
Oct 30 |
Medical and consumer genetics innovator Genefluence today announces the first use of its rapid, near-patient diagnostic platform to screen for urinary tract infections (UTIs), at the Royal Hospital Chelsea. The lab-free test is being used to identify, confirm and guide the treatment of UTIs on the spot, helping clinicians choose the most effective medication immediately rather than relying on trial-and-error broad-spectrum antibiotics – and helping to reduce the risk of antimicrobial resistance (AMR).
More
View more articles
DEBUG COMPARISON: Raw Model.Items (Showing Duplicates if any exist)
- Raw Item: PharmaForceIQ Launches Share of Answer Module to Evaluate and Act on AI Visibility (Nov 12, 2026)
- Raw Item: One Year After Launch, Plasmidsaurus RNA-Seq Challenges RT-qPCR as the Standard for Routine Gene Expression Analysis (Nov 12, 2026)
- Raw Item: Yourgene Health Insight DPYD Assay Secures TGA Regulatory Approval in Australia (Nov 12, 2026)
- Raw Item: START Expands its Global Early Phase Cancer Site Network into Italy Through Strategic Partnership with Istituti Fisioterapici Ospitalieri (Nov 12, 2026)
- Raw Item: Biognosys Launches Industrialized Discovery to Deliver Scalable, AI-ready Proteomics with Exceptional Cost Efficiency (Nov 12, 2026)
- Raw Item: Lilly Brings FDA-Approved GLP-1 Treatments to Hims & Hers Digital Platform (Nov 12, 2026)
- Raw Item: Wellness Claims Offer Little Cover for Diagnostic Tests, Regulatory Expert Warns (Nov 10, 2026)
- Raw Item: Pulmonary Hypertension: Impacts Beyond the Heart and Lungs (Nov 05, 2026)
- Raw Item: Normal Genomes Carry More “Pathogenic” Variation Than You’d Think (Nov 03, 2026)
- Raw Item: Normal Genomes Carry More “Pathogenic” Variation Than You’d Think (Nov 03, 2026)
- Raw Item: CluePoints Announced as Fierce Life Sciences Innovation Awards Finalist (Oct 30, 2026)
- Raw Item: Takara Bio Europe Introduces GMP-Grade Cellartis® MSC EV Wonder™ to Support Clinical-Scale Extracellular Vesicle Production (Oct 30, 2026)
- Raw Item: DCN Dx Acquires Human Biospecimen Provider BioSouthTech to Broaden Access to Diverse Patient Populations (Oct 30, 2026)
- Raw Item: Genefluence’s rapid, near-patient PCR test for urinary tract infections in first use at the Royal Hospital Chelse (Oct 30, 2026)
- Raw Item: Tiny Health Raises $33M for Microbiome Testing, Sava Lands $36M for Glucose Monitor (Oct 28, 2026)